SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new ...

Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed ...

Implantable cardiac monitors (ICMs) continuously monitor the patient's electrocardiogram and perform real-time analysis of the heart rhythm, for up to 36 months. The current clinical use of ICMs ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared a next-generation AI-powered remote ECG monitoring device. The ...

Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, ...

New study presented at HRX Live 2025 demonstrates continued advancement of company’s AI program HeartBeam's AI algorithm performed equally well on HeartBeam 3D ECG system and standard 12L ECGs in ...

It was stable on an actively beating heart, at body temperature, for 60 days, about the same time temporary pacemakers are used as a bridge to permanent pacemakers. What’s more, the device’s ...

Wearable health devices such as smartwatches and bands are more than fitness trackers. Many also can monitor your cardiovascular health. Some wearables can highlight problems such as irregular heart ...

Computer science researchers at the University of Washington are testing a phone app to determine if it can accurately ...